首页|《中国溃疡性结肠炎诊治指南(2023年·西安)》治疗部分解读

《中国溃疡性结肠炎诊治指南(2023年·西安)》治疗部分解读

扫码查看
近年来,我国溃疡性结肠炎的患病率增长速率较快,提高治疗水平、改善患者预后非常必要。自1993年以来,我国连续制定了多个溃疡性结肠炎治疗方面的共识意见,从治疗目标、原则、药物应用等多方面进行阐述。2023年再次进行了共识意见的修订,并根据牛津分级,对循证证据进行了方法学验证,形成了我国第1版溃疡性结肠炎诊疗指南,本文就指南的治疗部分进行解读,并与2018年共识的治疗部分进行比较,帮助临床医生加深对溃疡性结肠炎治疗基本原则和进展的认识,规范临床行为,并能落实到临床实践工作中。
Interpretation of the treatment section of Chinese Clinical Practice Guideline on the Management of Ulcerative Colitis(2023,Xi'an)
In recent years,the incidence of ulcerative colitis(UC)in China has been rapidly increasing,high-lighting the necessity of improving treatment strategy to enhance patient prognosis.Since 1993,multiple consen-sus on the treatment of UC have been continuously formulated in China,elucidating various aspects including treatment goals,principles,and medical applications.In 2023,consensus was revised again,and methodological validation of evidence was conducted using the Oxford grading system,leading to the development of the first edi-tion of UC guidelines in China.This article aims to interpret the treatment section of the UC guidelines and com-pare it with the consensus on UC treatment from 2018,with the expectation of deepening clinical physicians'un-derstanding of the basic principles and advancements in UC treatment,standardizing clinical behavior,and imple-menting them in clinical practice.

ulcerative colitistreatmentguidelinesmedication management

杨红、钱家鸣

展开 >

中国医学科学院北京协和医学院北京协和医院消化内科(北京,100730)

溃疡性结肠炎 治疗 指南 药物管理

2024

中国中西医结合消化杂志
华中科技大学同济医学院,中国中西医结合学会消化系统疾病专业委员会,中华中医药学会脾胃病专业委员会

中国中西医结合消化杂志

CSTPCD
影响因子:1.363
ISSN:1671-038X
年,卷(期):2024.32(8)